Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111932964 | 11193296 | 4 | F | 20130326 | 20160721 | 20150616 | 20160802 | EXP | US-CELGENEUS-USA-2015061334 | CELGENE | 56.50 | YR | M | Y | 74.80000 | KG | 20160802 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111932964 | 11193296 | 1 | PS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | U | 21880 | 25 | MG | CAPSULES | ||||||
| 111932964 | 11193296 | 2 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | U | 21880 | 10 | MG | CAPSULES | ||||||
| 111932964 | 11193296 | 3 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | U | 21880 | 15 | MG | CAPSULES | ||||||
| 111932964 | 11193296 | 4 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | U | 21880 | 10 | MG | CAPSULES | ||||||
| 111932964 | 11193296 | 5 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | 2.5 MILLIGRAM | U | U | 21880 | 5 | MG | CAPSULES | |||||
| 111932964 | 11193296 | 6 | SS | VELCADE | BORTEZOMIB | 1 | Subcutaneous | U | U | 21880 | 2.5 | MG | UNKNOWN | ||||||
| 111932964 | 11193296 | 7 | SS | DECADRON | DEXAMETHASONE | 1 | Oral | U | U | 21880 | 40 | MG | UNKNOWN | /wk | |||||
| 111932964 | 11193296 | 8 | SS | ZOMETA | ZOLEDRONIC ACID | 1 | Intravenous drip | U | U | 21880 | 4 | MG | UNKNOWN | /month |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 111932964 | 11193296 | 1 | Plasma cell myeloma |
| 111932964 | 11193296 | 6 | Plasma cell myeloma |
| 111932964 | 11193296 | 7 | Plasma cell myeloma |
| 111932964 | 11193296 | 8 | Plasma cell myeloma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 111932964 | 11193296 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 111932964 | 11193296 | Dysphonia | |
| 111932964 | 11193296 | Pyrexia | |
| 111932964 | 11193296 | Tinnitus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 111932964 | 11193296 | 1 | 20130314 | 20130621 | 0 | |
| 111932964 | 11193296 | 2 | 20131015 | 20140108 | 0 | |
| 111932964 | 11193296 | 3 | 20140108 | 20140122 | 0 | |
| 111932964 | 11193296 | 4 | 20140213 | 20150226 | 0 | |
| 111932964 | 11193296 | 5 | 20150306 | 0 | ||
| 111932964 | 11193296 | 6 | 20130314 | 20130621 | 0 | |
| 111932964 | 11193296 | 7 | 20130314 | 20130621 | 0 | |
| 111932964 | 11193296 | 8 | 20130314 | 20130621 | 0 |